Log In
Print this Print this

Zymaxid gatifloxacin ophthalmic solution 0.5%

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionTopical gatifloxacin ophthalmic solution 0.5%
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationConjunctivitis
Indication DetailsTreat bacterial conjunctivitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today